rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Perk Pharmaceuticals Ltd. - Research Center
530673 PCRKPHA Group (P) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 11 Mar ' 10 Mar ' 09 Mar ' 08 Mar ' 07
Sources of funds
Owner's fund
Equity share capital 6.38 6.38 6.38 6.38 6.38
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus -0.72 -0.80 -1.13 -1.15 -0.85
Loan funds
Secured loans 0.02 0.27 0.33 0.46 0.35
Unsecured loans - - - - -
Total 5.68 5.86 5.59 5.69 5.89
Uses of funds
Fixed assets
Gross block 4.06 4.12 6.14 6.14 6.18
Less : revaluation reserve - - - - -
Less : accumulated depreciation 0.14 0.14 2.02 1.87 1.71
Net block 3.92 3.98 4.12 4.27 4.47
Capital work-in-progress - - - - -
Investments - - - - -
Net current assets
Current assets, loans & advances 3.16 2.73 1.88 2.25 2.36
Less : current liabilities & provisions 1.40 0.85 0.42 0.85 0.99
Total net current assets 1.77 1.88 1.46 1.40 1.37
Miscellaneous expenses not written - - - 0.02 0.04
Total 5.68 5.86 5.59 5.69 5.89
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - -
Contingent liabilities - - - - -
Number of equity sharesoutstanding (Lacs) 63.84 63.84 63.84 63.84 63.84
Close
Add Perk Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Perk Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close